Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XA1B
|
||||
| Former ID |
DIB009500
|
||||
| Drug Name |
RTA-301
|
||||
| Synonyms |
Peloruside; Peloruside A; Series 300, Reata; Microtubule stabilizers (cancer), Reata; Peloruside analogs (cancer), Reata
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543674] | ||
| Company |
University of Texas Southwestern Medical Center
|
||||
| Formula |
C27H48O11
|
||||
| Canonical SMILES |
[C@@]12(O[C@H](C[C@H]([C@H]1O)OC)C[C@H]([C@@H](C(=O)O[C<br />@@H](C[C@H](C[C@@H](C2(C)C)O)OC)/C(=C\[C@@H](CC)CO)/C)O<br />)OC)O
|
||||
| CAS Number |
CAS 257939-61-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Tubulin beta | Target Info | Inhibitor | [543674] | |
| PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
| Huntington disease | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.